Format

Send to

Choose Destination
Respirology. 2019 Jun 21. doi: 10.1111/resp.13629. [Epub ahead of print]

Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection.

Author information

1
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
2
Master de Biologie, École Normale Supérieure de Lyon, Université Claude Bernard Lyon I, Université de Lyon, Lyon, France.
3
Department of Molecular and Translational Sciences, Monash University, Melbourne, VIC, Australia.

KEYWORDS:

immunopathology; influenza virus; therapies

PMID:
31225681
DOI:
10.1111/resp.13629
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center